¡Ya estamos en !
Descubre más
Insulet
Acerca de: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Empleados: 5,400
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
5.8%
Neutral
92.3%
Negativo
1.9%
Gráficos de precios implementados con Lightweight Charts™